| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 05/26/2006 | WO2005059118A3 Stem cell targeting using magnetic particles |
| 05/26/2006 | WO2005058360A3 Radiation therapy and medical imaging using uv emitting nanoparticles |
| 05/26/2006 | CA2587795A1 Method of cardiac imaging with the use of hyperpolarized 13 c-pyruvate |
| 05/26/2006 | CA2586621A1 Contrast agents to target extracellular matrix |
| 05/26/2006 | CA2585308A1 A non-human animal alzheimer's disease model and uses thereof |
| 05/25/2006 | US20060110326 Toluidine blue o drug substance and use thereof for in vitro staining and chemotherapeutic treatment of dysplastic tissues |
| 05/25/2006 | US20060110325 Serotonin and catecholamine segment optimization technology |
| 05/24/2006 | EP1658814A2 Methods for evaluating pathologies or therapeutics in a rat carotid artery |
| 05/24/2006 | EP1658495A1 Novel chemiluminescent compounds and their use |
| 05/24/2006 | EP1658282A1 Novel chelating agents and chelates and their use |
| 05/24/2006 | EP1658049A2 Ferromagnetic particles and methods |
| 05/24/2006 | EP1263801B1 Tissue bulking and coating compositions |
| 05/24/2006 | EP1015585B1 Tie ligand homologues |
| 05/24/2006 | DE102004055729A1 Herstellung von zwei-oder mehrschichtig aufgebauten Mikrokapseln Production of two or multi-layered microcapsules |
| 05/24/2006 | CN1775291A New-type liver spleen lymph gland magnetic resonance contrast medium and its preparing method |
| 05/24/2006 | CN1775290A Method for establishing cervical vertebra disci regression model |
| 05/23/2006 | US7049336 Method for diagnosing neuronal diseases and for treating primary hemostasis deficiency |
| 05/23/2006 | US7049289 Labelled glutamine and lysine analogues |
| 05/23/2006 | US7048907 Synthesis, compositions and methods for the measurement of the concentration of stable-isotope labeled compounds in life forms and life form excretory products |
| 05/23/2006 | US7048906 Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions |
| 05/23/2006 | CA2351207C Radionuclide labeling of vitamin b12 and coenzymes thereof |
| 05/18/2006 | WO2006052691A2 Pet and magnetic resonance for screening alzheimer's disease therapeutics |
| 05/18/2006 | WO2006052292A1 Method for continuous visualization of a blood clot or plaque in a body lumen |
| 05/18/2006 | WO2006051732A1 Pharmaceutical preparation containing coated magnetic particles and method for production thereof, and diagnosis therapy system |
| 05/18/2006 | WO2006051198A1 Nanoparticles comprising an intracellular targeting element and preparation and use thereof |
| 05/18/2006 | WO2006051143A1 Heterocyclic ligands and the gadolinium (iii) complexes thereof with biomedical applications |
| 05/18/2006 | WO2006051142A1 1-pyrazolylethyl-1,4,7,10-tetraazacyclododecane-4,7,10-triacetic acids and application of the gadolinium (iii) complexes thereof in clinical diagnosis |
| 05/18/2006 | WO2005097672A3 Method for the production of carbon nanotubes that are ferromagnetically filled in part and carry biomolecules, and use thereof in diagnosis and therapy |
| 05/18/2006 | WO2005013810A3 Biodegradable embolic agents |
| 05/18/2006 | US20060107340 Calpain large subunit (n-CL4) cysteine protease gene disruptions, and compositions and methods related thereto |
| 05/18/2006 | US20060107338 Hepatic cirrhosis model animal and method of constructing the same |
| 05/18/2006 | US20060107336 Nonbacterial prostatitis model animal |
| 05/18/2006 | US20060106253 Process for the preparation of iopamidol and the new intermediates therein |
| 05/18/2006 | US20060106197 comprises protein transduction domains; nuclear localization sequences; fusion proteins; for reversible immortalization of cells |
| 05/18/2006 | US20060104941 Systemic inflammatory markers as diagnostic tools in the prevention of atherosclerotic diseases and as tools to aid in the selection of agents to be used for the prevention and treatment of atherosclerotic disease |
| 05/18/2006 | US20060104908 Polymerization method for the synthesis of polypeptide imaging agents |
| 05/18/2006 | US20060104907 Biologically potent analogues of the Dmt-Tic pharmacophore and methods of use |
| 05/18/2006 | US20060104906 Method and apparatus for producing contrast agents for magnetic resonance imaging |
| 05/18/2006 | US20060104905 Methods of screening agents for activity using teleosts |
| 05/18/2006 | US20060104904 Method of evaluating plant protection |
| 05/18/2006 | US20060104903 Model for evaluating the efficacy of locally applied antiproliferatives or other agents on neointimal hyperplasia, immunohistochemical and vascular cell cycle changes in balloon-injured rat carotid arteries |
| 05/18/2006 | US20060104902 Method of preselection patients for anti-VEGF, anti-HIF-1 or anti-thioredoxin therapy |
| 05/18/2006 | US20060104901 Preventing or treating epithelial tissue damage or hair loss |
| 05/18/2006 | US20060104899 Production and use of novel peptide-based agents for use with bi-specific antibodies |
| 05/18/2006 | CA2596543A1 Methods of treating hematological malignancies with nucleoside analog drugs |
| 05/18/2006 | CA2586220A1 Pet and magnetic resonance for screening alzheimer's disease therapeutics |
| 05/18/2006 | CA2584224A1 Gpr41 and modulators thereof for the treatment of insulin-related disorders |
| 05/17/2006 | EP1656953A1 Method for obtaining cellular material from breast ducts |
| 05/17/2006 | EP1656838A1 Food for testing life style-related diseases |
| 05/17/2006 | EP1573313A4 Transgenic mice expressing human cd20 and/or cd16 |
| 05/17/2006 | EP1007101B1 Improvements in or relating to diagnostic/therapeutic agents |
| 05/17/2006 | EP0807124B1 Monoclonal antibody against flt4 receptor tyrosine kinase and its use in diagnosis and therapy |
| 05/17/2006 | CN1774267A Amyloid-binding, metal-chelating agents |
| 05/17/2006 | CN1774205A Method for spatially resolved determination of magnetic particle distribution in an area of examination |
| 05/17/2006 | CN1774204A Method for the spatially resolved determination of physical, chemical and biological properties or state variables |
| 05/17/2006 | CN1774200A Arrangement and method for the spatially resolved determination of state variables in an examination area |
| 05/17/2006 | CN1773636A Water-base magnetic liquid and producing method thereof |
| 05/16/2006 | US7047063 Tissue site markers for in vivo imaging |
| 05/16/2006 | US7045678 Genetically engineered rodent animal models for identifying fibroblast growth factor expressing cells and diagnosis and treatment of tumors; antiproliferative agents |
| 05/16/2006 | US7045674 Animal model for preeclampsia |
| 05/16/2006 | US7045616 Expression vector coding polypeptides for use in the treatment of alzheimer's dieases and tumors |
| 05/16/2006 | US7045606 Chelate compound containing ligand with steroids, enzymes, hapten and antibodies |
| 05/16/2006 | US7045522 8-Azabicyclo[3.2.1]oct-2-ene and -octane derivatives technical field |
| 05/16/2006 | US7045503 Radiometal-binding peptide analogues |
| 05/16/2006 | US7045495 Combination of bryostatin and paclitaxel for treating cancer |
| 05/16/2006 | US7045134 Borellia burgdorferi epitope peptides |
| 05/16/2006 | US7045117 Method for tumor diagnosis comprising administering of palladium-substituted bacteriochlorophyll derivatives |
| 05/16/2006 | CA2291274C Uses of oil bodies |
| 05/11/2006 | WO2006050130A2 Glycan analysis using deuterated glucose |
| 05/11/2006 | WO2006048321A1 Multimodally modified cells used as an administrable form for active substances and as diagnostic particles |
| 05/11/2006 | WO2005044313A3 Conjugates of angiotensin ii and an imaging moiety |
| 05/11/2006 | WO2005034912A3 Ferromagnetic particles and methods |
| 05/11/2006 | US20060100903 Method of enhancing the efficiency of a pharmaceutical business |
| 05/11/2006 | US20060099660 Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof |
| 05/11/2006 | US20060099650 Toll-like receptor assays |
| 05/11/2006 | US20060099570 Device and method for non-invasive measurement of the individual metabolic rate of a substantially spherical metabolizing particle |
| 05/11/2006 | US20060099239 Dietary supplement for promoting removal of heavy metals from the body |
| 05/11/2006 | US20060099148 Methods and compositions for imaging |
| 05/11/2006 | US20060099146 NIR-sensitive nanoparticle |
| 05/11/2006 | US20060099145 Pharmaceutical preparation containing magnetic vesicular particles, manufacturing method thereof and diagnostic therapeutic system |
| 05/11/2006 | US20060099144 Tumor association of MDL-1 and methods |
| 05/11/2006 | US20060099142 Cancer associated araf1 protein kinase and its uses |
| 05/11/2006 | DE102004054084A1 Stent, comprising marker visible under use of x-rays and designed as string accommodated in groove |
| 05/11/2006 | DE102004053458A1 Strukturierte polymere Träger für die Massenspektrometrie und Verfahren zu deren Herstellung Structured polymeric carrier for mass spectrometry and processes for their preparation |
| 05/10/2006 | EP1655367A1 Modulators of tissue regeneration |
| 05/10/2006 | EP1655040A1 Contrast agent formulations for the visualization of the lymphatic system |
| 05/10/2006 | EP1655039A2 Immunoliposomes that optimize internalization into target cells |
| 05/10/2006 | EP1653987A2 Host defense factor x (hdfx) |
| 05/10/2006 | EP0684843B1 TECHNETIUM-99m LABELED PEPTIDES FOR DIAGNOSTIC IMAGING OF INFLAMMATION |
| 05/10/2006 | CN1771057A Releasable polymeric conjugates based on biodegradable linkers |
| 05/09/2006 | US7041790 Fibrinogen binding moieties |
| 05/09/2006 | US7041785 for treatment of inflammation, diabetic vasculopathy; enzyme resistance |
| 05/09/2006 | US7041648 Compositions and methods for treating female fertility |
| 05/09/2006 | US7041466 Mouse disease model for evaluation of prophylactic and therapeutic treatments of Chlamydia |
| 05/09/2006 | US7041437 Genes and methods for the screening of therapeutics useful for treating impaired glucose tolerance conditions, as well as diagnostics and therapeutic compositions for identifying or treating such conditions. |
| 05/09/2006 | US7041362 Methods for identification and verification |
| 05/09/2006 | US7041276 Administering the agent to a teleost and detecting a response in the teleost indicating angiogenesis activity |
| 05/09/2006 | US7041275 Irrigating fluid |
| 05/04/2006 | WO2006046200A1 Preparation of dispersions of particles for use as contrast agents in ultrasound imaging |
| 05/04/2006 | WO2006046155A2 Loadable polyphosphazene-comprising particles for therapeutic and/or diagnostic applications and methods of preparing and using the same |